Financhill
Back

Organon & Co. 10K Form

Buy
60

OGN
Organon & Co.

Last Price:
$8.10
Seasonality Move:
-11.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OGN News And Ratings

See the #1 stock for the next 7 days that we like better than OGN

OGN Financial Statistics

Sales & Book Value

Annual Sales: $6.2B
Cash Flow: $149M
Price / Cash Flow: 3.07
Annual Sales: $3.48
Price / Book: 2.32

Profitability

EPS (TTM): 0.71660
Net Income (TTM): $187M
Gross Margin: $3.3B
Return on Equity: 79.63%
Return on Assets: 1.4%

Organon & Co. Earnings Forecast

Key Organon & Co. Financial Ratios

  • The Gross Profit Margin over the past 9 years for OGN is 53.30%.
  • The Selling, General & Administrative Expenses for OGN have been equal to 27.69% of Gross Profit Margin.
  • The Research & Development expenses have been 5.98% of Revenue.
  • The Interest Expense is 269.52% of Operating Income.
  • The Net Earning history of OGN is 3.01% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 3 years.

Organon & Co. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: OGN
Website: organon.com

Debt

Debt-to-Equity Ratio: 9.74
Current Ratio: 1.75
Quick Ratio: 0.81

Price-to-Earnings

Trailing P/E Ratio: 11.25
Forward P/E Ratio: 2.19

OGN Technical Analysis vs Fundamental Analysis

Buy
60
Organon & Co. (OGN) is a Buy

Is Organon & Co. a Buy or a Sell?

  • Organon & Co. stock is rated a Buy
    The current Organon & Co. [OGN] share price is $8.10. The Score for OGN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.